Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
ACS Infectious Diseases
|
May 28, 2021
High Throughput Screening to Identify Selective and Nonpeptidomimetic Proteasome Inhibitors As Antimalarials
Lydia Mata-Cantero, Stanley C Xie, Mercedes García, et al.
Nature Communications
|
September 20, 2018
Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome
Jessica L Bridgford, Stanley C Xie, Simon A Cobbold, et al.
Cell Reports
|
November 28, 2019
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance
Tuo Yang, Lee M Yeoh, Madel V Tutor, et al.
Plos Biology
|
April 23, 2015
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance
Con Dogovski, Stanley C Xie, Gaetan Burgio, et al.
Nature Microbiology
|
August 7, 2019
The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis
Stanley C Xie, Riley D Metcalfe, Eric Hanssen, et al.
Plos Pathogens
|
July 8, 2025
Natural product-mediated reaction hijacking mechanism validates Plasmodium aspartyl-tRNA synthetase as an antimalarial drug target
Nutpakal Ketprasit, Chia-Wei Tai, Vivek Kumar Sharma, et al.
Journal of Medicinal Chemistry
|
October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
Stanley C Xie, David L Gillett, Natalie J Spillman, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Potent reaction hijacking inhibitors of <i>Plasmodium falciparum</i> asparagine tRNA synthetase
Xi Ye, Lisl Y Esherick, Nutpakal Ketprasit, et al.
Science (New York, N.Y.)
|
June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Stanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Plos Pathogens
|
December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo
Stanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
ACS Infectious Diseases
|
May 28, 2021
High Throughput Screening to Identify Selective and Nonpeptidomimetic Proteasome Inhibitors As Antimalarials
Lydia Mata-Cantero, Stanley C Xie, Mercedes García, et al.
Nature Communications
|
September 20, 2018
Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome
Jessica L Bridgford, Stanley C Xie, Simon A Cobbold, et al.
Cell Reports
|
November 28, 2019
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance
Tuo Yang, Lee M Yeoh, Madel V Tutor, et al.
Plos Biology
|
April 23, 2015
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance
Con Dogovski, Stanley C Xie, Gaetan Burgio, et al.
Nature Microbiology
|
August 7, 2019
The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis
Stanley C Xie, Riley D Metcalfe, Eric Hanssen, et al.
Plos Pathogens
|
July 8, 2025
Natural product-mediated reaction hijacking mechanism validates Plasmodium aspartyl-tRNA synthetase as an antimalarial drug target
Nutpakal Ketprasit, Chia-Wei Tai, Vivek Kumar Sharma, et al.
Journal of Medicinal Chemistry
|
October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
Stanley C Xie, David L Gillett, Natalie J Spillman, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Potent reaction hijacking inhibitors of <i>Plasmodium falciparum</i> asparagine tRNA synthetase
Xi Ye, Lisl Y Esherick, Nutpakal Ketprasit, et al.
Science (New York, N.Y.)
|
June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Stanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Plos Pathogens
|
December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo
Stanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Page
of 3